Introduction
IBCG and Johnson & Johnson have partnered to produce a new video series for healthcare professionals managing patients with bladder cancer. Learn more about Bladder Cancer Insights: Empowering Personalized Care.

Introduction

Management of Non-Muscle Invasive Bladder Cancer

Part 1: High Risk NMIBC

Part 2: Low and Intermediate Risk NMIBC

Diagnosis and Staging of Bladder Cancer

Treatment Considerations with BCG

Surveillance and Standard Biomarkers

This educational video series is brought to you by Janssen Biotech, Inc., and is not certified for continuing medical education. The consultants have been paid an honorarium by Janssen Biotech, Inc. The speakers are presenting on behalf of Johnson & Johnson and must present information in compliance with FDA requirements applicable to Johnson & Johnson. These presentations were produced in collaboration with IBCG and Janssen Pharmaceuticals, Inc., a Johnson & Johnson company.